Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
Journal: CJC Open
Year: 2022

In clinical practice, cardiac sarcoidosis (CS) has been an underdiagnosed phenomenon and is potentially associated with adverse clinical outcomes, including malignant arrhythmias.1Powell R.G.G. Paulin F.L. Flemming J. et al.Multiple ıntramyocardial masses in an otherwise healthy 35-year-old woman.CJC Open. 2021; 4: 432-434Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar,2Birnie D.H. Sauer W.H. Bogun F. et al.HRS expert consensus statement on the diagnosis and management of arrhy